文献速递产科

不伴前置胎盘的胎盘植入谱系疾病

Placenta Accreta Spectrum Without Placenta Previa.
PubMed 文献 · Obstet Gynecol · 2020-01-01

一项美国两家转诊中心2010年1月至2019年6月的回顾性队列研究,纳入351例病理确诊的胎盘植入谱系疾病并切除子宫的分娩。不伴前置胎盘者106例(30%),其产前诊断率、多学科团队管理率及侵入性胎盘植入比例均低于伴前置胎盘者,但严重母体并发症发生率相似(19% vs 20%)。

要点

  • 不伴前置胎盘的胎盘植入谱系疾病产前诊断率仅38%,远低于伴前置胎盘者的87%。
  • 不伴前置胎盘者接受多学科团队管理的比例更低(41% vs 86%)。
  • 尽管无前置胎盘且胎盘侵入程度较轻,两组严重母体并发症发生率相似(19% vs 20%)。

核心结论

  • 不伴前置胎盘的胎盘植入谱系疾病更难以在产前被诊断,可能错失多学科团队管理的机会。
  • 尽管无前置胎盘且胎盘侵入程度较轻,分娩时严重母体并发症发生率并未降低。
  • 作者认为,更广泛地识别胎盘植入谱系疾病高危患者可能改善早期临床诊断和患者结局。

研究设计与样本

  • 回顾性队列研究,纳入美国两家转诊中心2010年1月至2019年6月病理确诊的胎盘植入谱系疾病并切除子宫的分娩,共351例。
  • 比较伴前置胎盘组与不伴前置胎盘组的母体、妊娠及分娩特征,并评估手术结局和严重母体并发症复合指标。
  • 严重母体并发症复合指标包括输血8单位或以上血细胞、再次手术、肺水肿、急性肾损伤、血栓栓塞或死亡。
  • 采用逻辑回归分析,所有分析均控制分娩地点。

主要发现

  • 351例分娩中,106例(30%)分娩时无前置胎盘。
  • 不伴前置胎盘组产前诊断率38%(95%CI 28-48%),伴前置胎盘组87%(95%CI 82-91%)。
  • 不伴前置胎盘组接受多学科团队管理的比例41%(95%CI 31-51%),伴前置胎盘组86%(95%CI 81-90%)。
  • 不伴前置胎盘组侵入性胎盘植入(increta或percreta)比例51%(95%CI 41-61%),伴前置胎盘组80%(95%CI 74-84%)。
  • 不伴前置胎盘组宫腔镜手术史24%(95%CI 16-33%) vs 伴前置胎盘组6%(95%CI 3-9%);体外受精31%(95%CI 22-41%) vs 9%(95%CI 6-13%);既往剖宫产史64%(95%CI 54-73%) vs 93%(95%CI 89-96%),但每组多数均有既往剖宫产史。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate placenta accreta spectrum with and without placenta previa with regard to risk factors, antepartum diagnosis, and maternal morbidity. METHODS: We conducted a retrospective cohort study of pathology-confirmed placenta accreta spectrum deliveries with hysterectomy from two U.S. referral centers from January 2010-June 2019. Maternal, pregnancy, and delivery characteristics were compared among placenta accreta spectrum cases with (previa PAS group) and without (nonprevia PAS group) placenta previa. Surgical outcomes and a composite of severe maternal morbidities were evaluated, including eight or more blood cell units transfused, reoperation, pulmonary edema, acute kidney injury, thromboembolism, or death. Logistic regression was used with all analyses controlled for delivery location. RESULTS: Of 351 deliveries, 106 (30%) had no placenta previa at delivery. When compared with the previa group, nonprevia placenta accreta spectrum was less likely to be identified antepartum (38%, 95% CI 28-48% vs 87%, 82-91%), less likely to receive care from a multidisciplinary team (41%, 31-51% vs 86%, 81-90%), and less likely to have invasive placenta increta or percreta (51% 41-61% vs 80%, 74-84%). The nonprevia group had more operative hysteroscopy (24%, 16-33% vs 6%, 3-9%) or in vitro fertilization (31%, 22-41% vs 9%, 6-13%) and was less likely to have had a prior cesarean delivery (64%, 54-73% vs 93%, 89-96%) compared with the previa group, though the majority in each group had a prior cesarean delivery. Rates of severe maternal morbidity were similar in the two groups, at 19% (nonprevia) and 20% (previa), even after controlling for confounders (adjusted odds ratio for the nonprevia group 0.59, 95% CI 0.30-1.17). CONCLUSION: Placenta accreta spectrum without previa is less likely to be diagnosed antepartum, potentially missing the opportunity for multidisciplinary team management. Despite the absence of placenta previa and less placental invasion, severe maternal morbidity at delivery was not lower. Broader recognition of patients at risk for placenta accreta spectrum may improve early clinical diagnosis and patient outcomes.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Carusi DA, Fox KA, Lyell DJ, et al. Placenta Accreta Spectrum Without Placenta Previa. Obstet Gynecol. 2020. PMID: 32769646. doi:10.1097/AOG.0000000000003970

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。